Abstract
To study the efficacy of the combination of prednisolone and mebendazole for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a two-week course of prednisolone, 60 mg/day, and mebendazole, 10 mg/kg/day. The primary observation parameter was the number of patients who still had headaches after the two-week course of treatment. Forty-one patients were enrolled in the study. Four (10%) patients still had headaches after the two-week course of treatment and the median length of time until complete disappearance of headaches was three days. Serious side effects were not detected. Treatment for two weeks with the combination regimen of prednisolone and mebendazole is safe and beneficial in relieving headaches in patients with eosinophilic meningitis.
MeSH terms
-
Acetaminophen / administration & dosage
-
Acetaminophen / therapeutic use
-
Adolescent
-
Adult
-
Aged
-
Analgesics, Non-Narcotic / administration & dosage
-
Analgesics, Non-Narcotic / therapeutic use
-
Angiostrongylus cantonensis / drug effects
-
Angiostrongylus cantonensis / pathogenicity
-
Animals
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / therapeutic use*
-
Antinematodal Agents / administration & dosage
-
Antinematodal Agents / therapeutic use*
-
Eosinophilia / drug therapy*
-
Eosinophilia / parasitology
-
Female
-
Humans
-
Male
-
Mebendazole / administration & dosage
-
Mebendazole / therapeutic use*
-
Meningitis / drug therapy*
-
Meningitis / parasitology
-
Middle Aged
-
Pilot Projects
-
Prednisolone / administration & dosage
-
Prednisolone / therapeutic use*
-
Strongylida Infections / complications
-
Strongylida Infections / drug therapy
-
Treatment Outcome
Substances
-
Analgesics, Non-Narcotic
-
Anti-Inflammatory Agents
-
Antinematodal Agents
-
Acetaminophen
-
Mebendazole
-
Prednisolone